Ocular Therapeutix Inc (NASDAQ:OCUL) shares are on a roughly 4% dip today after the biotech firm released second-quarter financial results- a quarter that …
Spark Therapeutics Has a Viable Hep A Program on Its Hands Spark Therapeutics Inc (NASDAQ:ONCE) shares are jumping almost 20% after the biotech …
Ocular Therapeutix Inc (NASDAQ:OCUL) shares are sliding almost 5% today on the heels of the biotech firm’s President and CEO Antony Mattessich new …
Ibio Inc (NYSEMKT:IBIO) shares are rising fast in Wednesday’s trading session. Currently shares in the plant-based biopharmaceutical developer are up 13.
BTIG analyst Dane Leone is out today with a research note on shares of Ocular Therapeutix Inc (NASDAQ:OCUL), following Ocular’s receipt of a complete response …
Ocular Therapeutix Inc (NASDAQ:OCUL) shares slumped nearly 20% after the drug maker announced that it received a complete response letter (CRL) from the U.S.
Arena Pharmaceuticals, Inc. Arena Pharmaceuticals, Inc.
Ocular Therapeutix Inc (NASDAQ:OCUL) shares may have been falling almost 9% at the close on the heels of a class action lawsuit filed …
Ocular Therapeutix Inc Ocular Therapeutix Inc (NASDAQ:OCUL) investors seem to be concerned with the company’s future following the news that Antony Mattessich will succeed Dr. …
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is a biotech giant that continues to struggle, and ahead of the bell tomorrow, Cancaccord certainly is not …
